Tuesday, March 07, 2023 6:08:54 PM
Dyno makes a good point about not seeing any IND filings yet. As far as I know, Regeneron's REGN14287 hasn't started trials either. Some folks think there may be a Regeneron/ENZC link, since Suraj Saggar worked as trial investigator for REGEN-COV mAb's, and joined ENZC's advisory board in early 2022. If ENZC is pedal to the metal trying to close a deal with Regeneron, they might move slower with things like IPF Immune or ITV-1. But we can't know if they don't communicate.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM